“HCG” Spells FTC Lawsuit For Weight Loss Product Firm
This article was originally published in The Tan Sheet
Executive Summary
FTC is suing HCG Platinum and owner Kevin Wright after he declined a settlement over alleged deceptive marketing of human chorionic gonadotropin products. The firm was one of seven warned in an FDA/FTC 2011 joint action about unapproved new drugs and unsubstantiated claims.
You may also be interested in...
Agencies Target “Fraud-Driven” HCG Weight-Loss Ingredient
FDA and FTC warn seven firms that “homeopathic” HCG weight-loss products are unapproved new drugs with unsubstantiated claims. An FTC official says HCG is the latest “fraud driven” weight-loss ingredient.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.